title: Defining the role of radiofrequency ablation and stereotactic ablative radiotherapy in patients with high-risk, early-stage non-small cell lung cancer.
authors.affiliation: Department of Radiation Oncology, London Regional Cancer Program, London, Ontario, Canada.|Department of Radiation Oncology, VU University Medical Center, Amsterdam, the Netherlands.
authors.forename: Alexander V
authors.initials: AV
authors.lastname: Louie
authors.affiliation: Department of Radiation Oncology, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia.
authors.forename: Shankar
authors.initials: S
authors.lastname: Siva
authors.affiliation: Department of Radiation Oncology, VU University Medical Center, Amsterdam, the Netherlands.
authors.forename: Suresh
authors.initials: S
authors.lastname: Senan
mesh_terms: D002289:Carcinoma, Non-Small-Cell Lung / Q000532:radiotherapy*; D017115:Catheter Ablation / Q000379:methods*; D006801:Humans; D008175:Lung Neoplasms / Q000532:radiotherapy*; D016634:Radiosurgery / Q000379:methods*